You have read all your free articles, to continue reading subscribe to read the rest of this content.
Scientists at deCODE genetics in Iceland have discovered rare, protective loss-of-function variants that point to potential drug targets for nonalcoholic fatty liver disease (NAFLD). Last week, the scientists published a large genome-wide association study on nonalcoholic fatty liver disease (NAFAlready a subscriber Login You have read all your free articles,…
Alvotech and Oaktree Acquisition Corp II establish financing facilities to enhance the company’s capital position and to replace any redeemed capital as part of their proposed merger. The two parties agree to reduce the minimum cash condition outlined in the merger agreement, thereby enhancing Already a subscriber Login You have…
Despite some years of really struggling financially, Iceland has been able to maintain its position as a provider of unique experimental settings for drug discovery. Today life science in the country has never been stronger. Looking back 20-30 years the country has witnessed a dramatic leap forwaAlready a subscriber Login…
Coripharma has secured equity funding to further support its future growth through research and development of generic pharmaceutical products in addition to increased commercial outreach. The financing round is in line with the company's previously communicated plans and attracted significant inAlready a subscriber Login You have read all your free…
